MBXBF.US Microbix Biosystems Inc.

Healthcare Biotechnology USA Stocks
0.2030 USD
Close of Nov 15, 2026
0.1540 0.2320
Market cap
USD 27.8M
P/E
-
P/B
1.63x
ROE
-18.7%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Jun 2026.

Is MBXBF.US undervalued?

Graham number

The Graham number of Microbix Biosystems Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Microbix Biosystems Inc. fundamental analysis

No fundamental analysis for Microbix Biosystems Inc. yet.

Microbix Biosystems Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Microbix Biosystems Inc.

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures a wide range of critical biological materials and medical devices for the global diagnostics industry, notably test ingredients (Antigen business) used in immunoassays, quality assessment, and diagnostic-test products, such as test-controls under …

Full company profile